Back to Search
Start Over
The company and Shenzhen Xinlitai Pharmaceutical terminate the development, production and sales rights of Enarodustat (JTZ-951) in Taiwan
- Source :
- Taiwan Business News. March 25, 2024
- Publication Year :
- 2024
-
Abstract
- March 25 -- Ancheng Biotechnology Co., Ltd. issued the following news release: 1. Covenant or commitment end date: 113/03/25. 2. Contract or commitment content: Termination of Enarodustat (JTZ-951) Taiwan authorization [...]
- Subjects :
- Pharmaceutical industry -- Licensing agreements
Company licensing agreement
Subjects
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Taiwan Business News
- Publication Type :
- Periodical
- Accession number :
- edsgcl.787713972